Pre-clinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancer
- 28 October 2007
- journal article
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 6 (10) , 1632-1637
Abstract
Chemotherapy in prostate cancer (CaP) even as an adjunct has not been a success. In this communication, we report the pre-clinical efficacy of a nitroacridine derivative, C-1748 (9[2’-hydroxyethyla...Keywords
This publication has 44 references indexed in Scilit:
- Update on hormone-refractory prostate cancerCurrent Opinion in Urology, 2004
- Advances in prostate cancerCurrent Opinion in Oncology, 2004
- Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in childrenEuropean Journal of Cancer, 2004
- Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancerBritish Journal of Cancer, 2004
- Novel approaches to treat asymptomatic, hormone-naive patients with rising prostate-specific antigen after primary treatment for prostate cancerUrology, 2003
- Phase 3 randomized trial evaluating second-line hormonal therapy versus docetaxel-estramustine combination chemotherapy on progression-free survival in asymptomatic patients with a rising prostate-specific antigen level after hormonal therapy for prostate cancer: an Eastern Cooperative Oncology Group (E1899), intergroup/clinical trials support unit studyUrology, 2003
- Novel approaches to treating the asymptomatic hormone-refractory prostate cancer patientUrology, 2003
- An active regimen of weekly paclitaxel and estramustine in metastatic androgen-independent prostate cancerUrology, 2002
- A Phase II Study of CaelyxTM (Liposomal Doxorubicin) in Metastatic Carcinoma of the Prostate: Tolerability and Efficacy Modification by Liposomal EncapsulationInvestigational New Drugs, 2002
- Novel Clinical Trials in Androgen-Independent Prostate CancerClinical Prostate Cancer, 2002